 |
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Saturday, May 25, 2013
|
|
|
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Saturday, May 25, 2013
|
| Home | HealthTopics | Health Centers | Reference Library | Research |
 Join us on Facebook
|
Share on Facebook | Tweet |
|
In the management of advanced lung disease, when all other therapeutic options are exhausted, lung transplantation frequently provides an alternative for a wide range of patients in both the adult and pediatric age groups. Transplantation has been shown to improve quality of life, functional endurance, exercise tolerance, and survival in select patient groups.
Today, lung transplantation is considered a viable treatment for many patients with most transplants being performed for end-stage lung disease resulting from emphysema, pulmonary fibrosis, and cystic fibrosis. Additionally, other lung diseases such as those resulting from sarcoidosis, collagen vascular disorders, and pulmonary hypertension are also amenable to this therapy.
This article is a NetWellness exclusive.
Last Reviewed: Jan 06, 2010
|
David R Nunley, MD, FCCP Former Associate Professor College of Medicine The Ohio State University |
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|